Milestone Scientific Inc. (MLSS)
NYSEAMERICAN: MLSS · Real-Time Price · USD
0.678
+0.058 (9.35%)
At close: Nov 20, 2024, 4:00 PM
0.733
+0.054 (8.04%)
After-hours: Nov 20, 2024, 7:14 PM EST
Milestone Scientific Revenue
Milestone Scientific had revenue of $2.51M in the quarter ending September 30, 2024, with 22.07% growth. This brings the company's revenue in the last twelve months to $8.88M, down -9.49% year-over-year. In the year 2023, Milestone Scientific had annual revenue of $9.83M with 11.60% growth.
Revenue (ttm)
$8.88M
Revenue Growth
-9.49%
P/S Ratio
6.00
Revenue / Employee
$522,177
Employees
17
Market Cap
52.40M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.83M | 1.02M | 11.60% |
Dec 31, 2022 | 8.81M | -1.50M | -14.54% |
Dec 31, 2021 | 10.30M | 4.87M | 89.52% |
Dec 31, 2020 | 5.44M | -2.94M | -35.07% |
Dec 31, 2019 | 8.37M | -1.25M | -12.97% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
LakeShore Biopharma | 79.42M |
OptiNose | 75.67M |
Apyx Medical | 48.54M |
BGM Group | 29.87M |
Rapid Micro Biosystems | 26.17M |
Kronos Bio | 9.87M |
vTv Therapeutics | 1.00M |
CollPlant Biotechnologies | 689.00K |
MLSS News
- 5 days ago - Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024 - GlobeNewsWire
- 6 days ago - Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO - GlobeNewsWire
- 8 days ago - Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call - GlobeNewsWire
- 19 days ago - Milestone Scientific Expands Commercial Rollout of the CompuFlo® Epidural System with Esteemed Pain Management Physician Dr. Elbaz at Hudson Specialty Care - GlobeNewsWire
- 6 weeks ago - Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at iHeal Pain Center Following Medicare Price Assignment - GlobeNewsWire
- 3 months ago - Milestone Scientific Inc. (MLSS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024 - GlobeNewsWire